MarkSchoenbergMD

PubMed

• 58 citations
  A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.
  Tian C. Zhou, Alexander Sankin, Steven A. Porcelli, David S. Perlin, Mark Schoenberg, Xingxing Zang> ;Urologic Oncology. 2017 Jan 1
• 15 citations
  Accuracy of urethral frozen section during radical cystectomy for bladder cancer
  Max Kates, Mark W. Ball, Meera Chappidi, Alexander S. Baras, Jennifer Gordetsky, Nikolai A. Sopko, Aaron Brant, Phillip M. Pierorazio, Jonathan I. Epstein, Mark Schoen...> ;Urologic Oncology. 2016 Dec 1
• 18 citations
  Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines☆
  Bernd J. Schmitz-Dräger, Eva C. Kuckuck, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Amanda F. Saltzman, Abhishek Kumar Srivastava, M'Liss A. Hudson, Roland Seiler, T...> ;Urologic Oncology. 2016 Oct 1
• 6 citations
  Infectious complications in transfused patients after radical cystectomy.
  Jen-Jane Liu, Patrick Mullane, Max Kates, Nilay M. Gandhi, Mark Schoenberg, Charles G. Drake, Noah M. Hahn, Steven M. Frank, Trinity J. Bivalacqua> ;The Canadian Journal of Urology. 2016 Aug 1
• 22 citations
  A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer
  Jong Chul Park, Nilay M. Gandhi, Michael A. Carducci, Mario A. Eisenberger, Alexander S. Baras, Georges J. Netto, Jen-Jane Liu, Charles G. Drake, Mark P. Schoenberg, T...> ;The Journal of Urology. 2016 Apr 1
• 124 citations
  The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothe...
  Alexander S. Baras, Charles G. Drake, Jen-Jane Liu, Nilay M. Gandhi, Max Kates, Mohamed O Hoque, Alan K. Meeker, Noah M. Hahn, Janis M. Taube, Mark Schoenberg, George ...> ;Oncoimmunology. 2016 Feb 18
• 18 citations
  Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics...
  Deborah R. Kaye, Joseph K. Canner, Max Kates, Mark P. Schoenberg, Trinity J. Bivalacqua> ;Bladder Cancer. 2016 Apr 27
• 1 citations
  Erratum: Characteristics and outcomes of patients with clinical t1 grade 3 urothelial carcinoma treated with radical cystectomy: Results from an international cohort (...
  Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, Claudio Jeldres, Pierre I. Karakiewicz, Giacomo Novara, Eila C. Skinner, Stefan Denzinger, Yves Fradet, Hend...> ;European Urology. 2015 Jul 1
• 33 citations
  Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes
  Nilay M. Gandhi, Alexander S. Baras, Enrico Munari, Sheila F. Faraj, Leonardo Oliveira Reis, Jen-Jane Liu, Max Kates, Mohammad O. Hoque, David M. Berman, Noah M. Hahn,...> ;Urologic Oncology. 2015 May 1
• 23 citations
  Tissue-Engineered Urinary Conduits
  Max Kates, Anirudha Singh, Hotaka Matsui, Gary D. Steinberg, Norm D. Smith, Mark P. Schoenberg, Trinity J. Bivalacqua> ;Current Urology Reports. 2015 Feb 13
• The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
  Helena Furberg, Mark P. Schoenberg> ;Urologic Oncology. 2015 Jan 1
• 18 citations
  Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.
  Michael A. Gorin, Max Kates, Jeffrey K. Mullins, Phillip M. Pierorazio, Brian R. Matlaga, Mark P. Schoenberg, Trinity J. Bivalacqua> ;The Canadian Journal of Urology. 2014 Feb 25
• 12 citations
  In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States
  Max Kates, Michael A. Gorin, Christopher M. Deibert, Phillip M. Pierorazio, Mark P. Schoenberg, James M. McKiernan, Trinity J. Bivalacqua> ;Urologic Oncology. 2014 Jan 1
• 34 citations
  Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder
  Wassim Kassouf, Robert S. Svatek, Shahrokh F. Shariat, Giacomo Novara, Seth P. Lerner, Yves Fradet, Patrick J. Bastian, Armen Aprikian, Pierre I. Karakiewicz, Hans-Mar...> ;Urologic Oncology. 2013 May 1
• Plagiarism.
  Droller, M. J., , Bahnson, R. R., Lerner, S. P., Schoenberg, M., Thalmann, G. A.> ;Urol Oncol. 2012 Sep
• 46 citations
  Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
  Hang Wang, Roula Albadine, Ahmed Magheli, Thomas J. Guzzo, Mark W. Ball, Stefan Hinz, Mark P. Schoenberg, George J. Netto, Mark L. Gonzalgo> ;Urologic Oncology. 2012 Jul 1
• 24 citations
  Ureteral Stents Placed at the Time of Urinary Diversion Decreases Postoperative Morbidity
  Jeffrey K. Mullins, Thomas J. Guzzo, Mark W. Ball, Phillip M. Pierorazio, John B. Eifler, Thomas W. Jarrett, Mark P. Schoenberg, Trinity J. Bivalacqua> ;Urologia Internationalis. 2012 Jan 4
• 25 citations
  Smoking Knowledge Assessment and Cessation Trends in Patients With Bladder Cancer Presenting to a Tertiary Referral Center
  Thomas J. Guzzo, Mark Hockenberry, Phillip Mucksavage, Trinity J. Bivalacqua, Mark P. Schoenberg> ;Urology. 2012 Jan 1
• 42 citations
  The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
  Thomas J. Guzzo, Brian K. McNeil, Trinity J. Bivalacqua, Debra J. Elliott, Lori J. Sokoll, Mark P. Schoenberg> ;Urologic Oncology. 2012 Jan 1
• 77 citations
  Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
  Guru Sonpavde, Myrna M. Khan, Seth P. Lerner, Robert S. Svatek, Giacomo Novara, Pierre I. Karakiewicz, Eila C. Skinner, Derya Tilki, Wassim Kassouf, Yves Fradet, Colin...> ;The Journal of Urology. 2011 Feb 1
• 56 citations
  Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
  Luciana Schultz, Roula Albadine, Jessica Hicks, S. Jadallah, Angelo M. DeMarzo, Ying Bei Chen, Matthew E. Neilsen, Mark L. Gonzalgo, David Sidransky, Mark P. Schoenber...> ;Cancer. 2010 Dec 1
• 2 citations
  Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?
  Trinity J. Bivalacqua, Stacy Loeb, Phillip M. Pierorazio, Mark P. Schoenberg, Alan W. Partin, Thomas J. Guzzo> ;Urologia Internationalis. 2010 Nov 13
• 2 citations
  Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum.
  Phillip M. Pierorazio, Thomas J. Guzzo, Misop Han, Trinity J. Bivalacqua, Jonathan I. Epstein, Edward M. Schaeffer, Mark P. Schoenberg, Patrick C. Walsh, Alan W. Partin> ;Urology. 2010 Sep 1
• 102 citations
  The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
  Robert S. Svatek, Shahrokh F. Shariat, Robert E. Lasky, Eila C. Skinner, Giacomo Novara, Seth P. Lerner, Yves Fradet, Patrick J. Bastian, Wassim Kassouf, Pierre I. Kar...> ;Clinical Cancer Research. 2010 Sep 1
• 57 citations
  Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
  Derya Tilki, Robert S. Svatek, Giacomo Novara, Michael Seitz, Guilherme Godoy, Pierre I. Karakiewicz, Wassim Kassouf, Yves Fradet, Hans-Martin Fritsche, Guru Sonpavde,...> ;The Journal of Urology. 2010 Sep 1
• Join now to see all